Category: Boston

Navitor Pharmaceuticals Obtains $23,500,000 Series A Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7b720c81-c6f8-465e-b1f3-4db8f48a44de Date 6/20/2014 Company Name Navitor Pharmaceuticals Mailing Address 700 Main Street Cambridge, MA 02139 USA Company Description New scientific insights are emerging regarding the primal signaling pathways that direct an organism’s metabolic response to conditions in its environment—such as dynamic changes in the availability of nutrients, energy, oxygen and other factors—and … Continue reading “Navitor Pharmaceuticals Obtains $23,500,000 Series A Funding”

Path Acquires TalkTo for Undisclosed Sum

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2d29d1ef-af4a-4f27-8bd5-57422197f578 Date 6/20/2014 Company Name TalkTo Mailing Address 130 Prospect Street 1st Floor Cambridge, MA 02139 USA Company Description We’re TalkTo, and we’re making it possible to text any business as easily as you text a friend. Website http://www.talkto.com Transaction Type M&A Transaction Amount Undisclosed Transaction Round Proceeds Purposes M&A Terms Finncial … Continue reading “Path Acquires TalkTo for Undisclosed Sum”

Sanofi Punts Cancer Drug Back to Merrimack

Merrimack Pharmaceuticals has been saying for some time that the Phase 2 studies of its cancer drug, MM-121, while missing their goals, have been helping it find the right groups of patients for a late-stage trial. Apparently, however, Sanofi isn’t buying that thesis. Merrimack (NASDAQ: [[ticker:MACK]]) said today that Sanofi has returned worldwide rights to … Continue reading “Sanofi Punts Cancer Drug Back to Merrimack”

Amazon’s Fire Phone: One Big Piece of a Real-World Shopping Push

Anyone who’s fallen into a wormhole of product recommendations can testify that buying things on Amazon.com is already pretty easy. With an Internet connection and a bank card, just about anything you can dream up is available around the clock, ready to be shipped to your door. But some things haven’t changed all that much … Continue reading “Amazon’s Fire Phone: One Big Piece of a Real-World Shopping Push”

BIO 2014: An Industry Surrounded by Insurmountable Opportunity

Biotech is riding the crest of a wave of public and private financial interest unparalleled in the 36-years since the founding of Genentech. Since 2012 public markets have committed $10.3 billion to more than 100 life-sciences IPOs, an industry record. Pharma has been buying/partnering with biotech on an unprecedented scale. Research breakthroughs from cancer immunotherapy … Continue reading “BIO 2014: An Industry Surrounded by Insurmountable Opportunity”

Boston VC Firms, Pharmas Team up on $23.5M Series A For Navitor

For close to a year, Navitor Pharmaceuticals has been quietly working behind the scenes with scientists at the Whitehead Institute on an approach to hit a well-known disease target in a novel way. Now the Cambridge, MA-based startup is stepping out of the shadows to unveil its plan with a big round of financing. Today, … Continue reading “Boston VC Firms, Pharmas Team up on $23.5M Series A For Navitor”

Continuus Lands $2,000,000 Series A Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d5806faa-e1a2-48d9-827a-750207c9c4e2 Date 6/19/2014 Company Name Continuus Mailing Address 4 Longfellow Place Boston, MA 02114 USA Company Description Although the pharmaceutical industry excels in the discovery of new therapeutics, it is behind many other industries in the way it manufactures its products through batch processes. Batch manufacturing is an outdated methodology that suffers … Continue reading “Continuus Lands $2,000,000 Series A Financing”

Pixability Receives $4,000,000 Series B Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=87a02821-582a-4ea4-90d3-c3cb1ac3ed8f Date 6/19/2014 Company Name Pixability Mailing Address 123 North Washington Street 2nd Floor Boston, MA 02114 USA Company Description We offer the easiest, quickest, most economical way to create quality video to help you market your company or organization. Now anyone, from company president to cashier, can be part of the … Continue reading “Pixability Receives $4,000,000 Series B Funding Round”

Seventh Sense Biosystems Lands $450,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8f52008d-a919-4e84-82dd-c68344a672d2 Date 6/19/2014 Company Name Seventh Sense Biosystems Mailing Address 286 Cardinal Medeiros Avenue Cambridge, MA 02141 USA Company Description The company’s proprietary TAP Touch Activated Phlebotomy technology enables painless, convenient and safe blood collection and is the foundation for a rich pipeline of products from painless, one-step sampling to integrated collection … Continue reading “Seventh Sense Biosystems Lands $450,000 New Financing”

New WiTricity CEO: 2015 Will Show “Real Progress” for Wireless Power

[Updated 2:15 p.m.] It’s easy to forget that, just a decade ago, wireless Internet access wasn’t the first-world commodity we take for granted today. As the head of HP’s “mobile computing group” back then, Alex Gruzen had seen wi-fi make some steps toward the mainstream. But the true leap, he recalls, wouldn’t come until Intel … Continue reading “New WiTricity CEO: 2015 Will Show “Real Progress” for Wireless Power”

“We Have to Find Our Way”: Eric Topol of Scripps on Connected Health

Eric Topol wears many hats. He is a practicing cardiologist, genomic researcher, chief academic officer of Scripps Health, and the head of the Scripps Translational Science Institute, one of more than 60 biomedical centers supported through an ambitious National Institutes of Health program created nearly 10 years ago to move basic medical research into the … Continue reading ““We Have to Find Our Way”: Eric Topol of Scripps on Connected Health”

GenePeeks Takes on Preconception Testing With “Digital Babies”

Sperm banks only screen their donors for a handful of genetic diseases. Unfortunately, there are many more than that a donor could carry without having any telltale symptoms—and which could be passed on to a child. A startup called GenePeeks is looking to improve peoples’ odds of having a healthy baby—and beat a path towards … Continue reading “GenePeeks Takes on Preconception Testing With “Digital Babies””

Sage Therapeutics Readies IPO Pitch to Develop CNS Drugs

Sage Therapeutics made it pretty clear it was plotting an IPO when it added a group of public investment funds to its latest private financing round a few months ago. The Cambridge, MA-based company followed through today, filing papers outlining plans to tap Wall Street to develop drugs for rare neurological disorders. Sage aims to … Continue reading “Sage Therapeutics Readies IPO Pitch to Develop CNS Drugs”

Onapsis Secures $9,580,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9a45674e-6d9d-49b7-affd-0d17a3e02a2e Date 6/18/2014 Company Name Onapsis Mailing Address 1 Broadway 3rd Floor Cambridge, MA 02142 USA Company Description Onapsis Inc. is the leading provider of solutions to protect ERP systems from cyber-attacks. Through our innovative software solutions, our global customers can secure their SAP and Oracle business-critical platforms from espionage, sabotage and … Continue reading “Onapsis Secures $9,580,000 New Financing”

Selecta Biosciences Garners $9,350,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c6495fd4-cf4d-4bf0-af16-1cc1a5895ab6 Date 6/18/2014 Company Name Selecta Biosciences Mailing Address 480 Arsenal St. Building One Watertown, MA 02472 USA Company Description Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications. Website http://www.selectabio.com … Continue reading “Selecta Biosciences Garners $9,350,000 New Financing”

Repsly Secures New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a6b83a3f-8da5-431b-bce4-61adb623f859 Date 6/18/2014 Company Name Repsly Mailing Address 745 Atlantic Ave. Boston, MA 02111 USA Company Description Repsly has been focused on providing mobile software solutions for enhancing field activity management since its inception in 2010. Setting out to simplify processes for field teams and their managers, Repsly has customers in over … Continue reading “Repsly Secures New Funding”

Zerto Receives $26,000,000 Series D Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ba93c347-11c9-4812-857c-ac40c11c4697 Date 6/18/2014 Company Name Zerto Mailing Address 27-43 Wormwood Street Boston, MA 02210 USA Company Description Zerto is the industry’s first hypervisor-based, virtual-aware, replication solution for tier-one applications. It closes a critical gap in cloud and enterprise business continuity and disaster recovery (BC/DR). Website http://www.zerto.com Transaction Type Venture Equity Transaction Amount … Continue reading “Zerto Receives $26,000,000 Series D Funding Round”

One More Thought From Boston 2034: Tech + Biotech + Cleantech = ?

When we assembled some of the top business leaders and thinkers across New England for Boston 2034 last week, I noticed a high-level theme: we were trying to break down barriers between innovation sectors. Like most communities, Boston is pretty segregated by industry. The tech people don’t know their Agios from their Acceleron (both public … Continue reading “One More Thought From Boston 2034: Tech + Biotech + Cleantech = ?”

CloudHealth Garners $3,200,000 Series A Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2f483bba-c44a-449d-b4ca-03bb3a8ae3cf Date 6/17/2014 Company Name CloudHealth Mailing Address 280 Summer Street 6th Floor Boston, MA 02210 USA Company Description CloudHealth provides business performance management for the cloud. We poll, collect, aggregate, and correlate data from your cloud ecosystem 7 by 24, and allow our customers to analyze, model, predict, and plan their … Continue reading “CloudHealth Garners $3,200,000 Series A Financing”

BioCatch Obtains $10,000,000 Series A Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ea63c2fc-ed26-4845-9445-5ad8c8d3749a Date 6/17/2014 Company Name BioCatch Mailing Address 155 Seaport Blvd. Boston, MA 02210 USA Company Description BioCatch takes behavioral biometrics technology to the next level by leveraging a truly unique approach. Our goal is to equip the industry with a real game-changer in the fight against advanced cyber threats. Website http://www.biocatch.com … Continue reading “BioCatch Obtains $10,000,000 Series A Funding”

RailPod Lands $2,500,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ae435964-315f-420f-b9be-cd7e9b7e5c4c Date 6/17/2014 Company Name RailPod Mailing Address Undisclosed Boston, MA 95113 USA Company Description RailPod provides the inspector with a visual depiction of the track environment supported by quantifiable measurements to enable the inspector to quickly and accurately identify track problems. Website http://www.rail-pod.com Transaction Type Venture Equity Transaction Amount $2,500,000 Transaction … Continue reading “RailPod Lands $2,500,000 New Financing”

HighRoads Receives $3,713,400 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=393feb52-54c5-4626-8cbb-0205b4c0e711 Date 6/17/2014 Company Name HighRoads Mailing Address 3 Burlington Woods Burlington, MA 01803 USA Company Description IE-Engine Inc. is the leading developer of Human Resource Cost Management (HRCM) software. The Company’s Web-based applications enable HR decision makers at Global 1000 organizations to make better strategic decisions, reduce costs and increase the … Continue reading “HighRoads Receives $3,713,400 New Financing Round”

Draker Laboratories Secures $5,407,845 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1d4cb980-eee5-4e4a-9b07-34810d020064 Date 6/17/2014 Company Name Draker Laboratories Mailing Address 431 Pine Street Burlington, VT 05401 USA Company Description Draker Laboratories provides high performance hardware monitoring and software-as-a-service data management systems for commercial-scale renewable energy systems including: solar photovoltaics (PV), wind, solar thermal and hybrid systems. Website http://www.drakerlabs.com Transaction Type Venture Equity Transaction … Continue reading “Draker Laboratories Secures $5,407,845 New Financing Round”

The Future of Work, Plus or Minus E-mail

I. Too Much of a Good Thing I’ll begin by admitting my biases. I don’t like electronic mail. In the pre-Internet days of the 1970s, when e-mail as we know it was invented, it may have been a decent solution to a certain problem—namely, the need for users logged into a single mainframe, server, or … Continue reading “The Future of Work, Plus or Minus E-mail”

CounterTack Secures $5,000,000 Series B Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9df5deff-afaa-488f-95fa-0551ae64091d Date 6/16/2014 Company Name CounterTack Mailing Address 100 Fifth Ave. First Floor Waltham, MA 02451 USA Company Description CounterTack is the industry’s first and only in-progress attack intelligence and response solution that enables enterprise and government organizations to combat advanced targeted attacks with a new line of defense. Website http://www.countertack.com Transaction … Continue reading “CounterTack Secures $5,000,000 Series B Funding Round”

Brain Parade Receives $100,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=73089cf1-7a84-47be-9df8-6fdb3183953d Date 6/16/2014 Company Name Brain Parade Mailing Address 1177 High Ridge Rd. Stamford, CT 06905 USA Company Description Brain Parade is a developer of learning solutions for children with autism and other special needs. The company is the creator of See.Touch.Learn., an iPad application and online community, which serves as a … Continue reading “Brain Parade Receives $100,000 New Funding Round”

Bluebird’s Gene Therapy Quickly Halts Blood Disease in Small Study

As a gene therapy company, Bluebird Bio was a surprising IPO star in 2013. After all, it’s working in a field that was kicked to the curb in the previous decade. What’s more, it made its IPO pitch on the back of the slimmest amount of data. But details from a new study released this … Continue reading “Bluebird’s Gene Therapy Quickly Halts Blood Disease in Small Study”

Boston Tech Roundup: Boston-Power, Imprivata, CloudLock, & More

There’s fundraising news big and small, along with an acquisition, in this wrapup of the week’s Boston-area innovation headlines: —A Boston-bred cleantech company is rearing its head again, spurred on by competition with Elon Musk’s Tesla Motors. The Wall Street Journal reports that Boston-Power, a developer of advanced lithium ion battery technology, is raising $250 … Continue reading “Boston Tech Roundup: Boston-Power, Imprivata, CloudLock, & More”

Innovation Hub: Twitter’s Deb Roy Sees More Change Ahead for TV

It’s fair to say that Deb Roy is obsessed with Twitter. In 2008, he started Bluefin Labs to understand the power and influence of social media. He looked at how the public viewed political candidates, brands, and TV shows. And the data he gathered was so valuable that last year, Twitter gobbled up Bluefin, making … Continue reading “Innovation Hub: Twitter’s Deb Roy Sees More Change Ahead for TV”

How I Conquered My Reading List Using Pocket

If you’re a student, a researcher, a knowledge worker, or an entrepreneur, you probably swim in ideas all day long. Like it or not, replenishing those ideas through reading is a huge part of your job. After all, it’s hard to make new knowledge without old knowledge; it’s impossible to see new connections unless you … Continue reading “How I Conquered My Reading List Using Pocket”

Boston 2034: Photos From Our Look at the Next 20 Years

Predicting the next five years can seem like a pretty tall order these days. So why organize an all-day conference around the idea of sketching out the next two decades? Well, for starters, that’s how you get people thinking big. And the speakers at Boston 2034, our biggest and boldest conference yet, certainly didn’t disappoint. … Continue reading “Boston 2034: Photos From Our Look at the Next 20 Years”

Chrono Therapeutics Receives $32,000,000 Series A Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5dfb0d77-f0af-4b4d-acaa-788160c49890 Date 6/13/2014 Company Name Chrono Therapeutics Mailing Address 1377 Main St. Waltham, MA 02451 USA Company Description Chrono Therapeutics (CHRONO) is a pharmaceutical company founded in 2004 with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery (TDD) that offers real-time … Continue reading “Chrono Therapeutics Receives $32,000,000 Series A Financing Round”

PCC Technology Group Secures $5,500,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d63fba20-a296-406e-bd00-aeccd08e8656 Date 6/13/2014 Company Name PCC Technology Group Mailing Address 2 Barnard Ln. Bloomfield, CT 06002 USA Company Description We help our customers provide enhanced services in a more efficient manner to their customers and constituents. Our software tools solve business problems by providing decision support, enhancing productivity and improving quality. Website … Continue reading “PCC Technology Group Secures $5,500,000 New Funding”

Moderna, Changing Its Identity, Plots Army of mRNA Spinouts

Kendall Square has found its newest biotech incubator. Moderna Therapeutics just had no idea it’d be the one running it. Moderna, the high-flying, privately held startup that raised more than $400 million through a string of deals and financings over the few years without even having a drug in the clinic yet, is moving into … Continue reading “Moderna, Changing Its Identity, Plots Army of mRNA Spinouts”

TaskRabbit CEO: Better Job Market Hasn’t Dampened Appeal

When Leah Busque founded TaskRabbit in Boston back in 2008 (under the name RunMyErrand), the terms “sharing economy” and “collaborative consumption” weren’t part of the tech lexicon, much less the national one. Home rental service Airbnb was founded around the same time, and car-for-hire king Uber wouldn’t even exist until the next year. Six years … Continue reading “TaskRabbit CEO: Better Job Market Hasn’t Dampened Appeal”

Robots for Grandma: 3 Big Problems to Tackle as the Population Ages

A future of robotic assistants and self-driving cars isn’t so far away. Just look at some of the luxury cars on the market today, Rethink Robotics founder Rodney Brooks says.  The Mercedes-Benz S Class, for example, is loaded with sensors that can detect the roadway and take over the car’s safety systems, from tightening the … Continue reading “Robots for Grandma: 3 Big Problems to Tackle as the Population Ages”

10 Thoughts on the Future of Innovation From Boston 2034

Twenty years is a long time. Yet, to many of us, 1994 doesn’t feel all that long ago. So it seems like about the right amount to look forward as we think about the future of technology, society, and innovation. And look forward we did. At our Boston 2034 conference on Tuesday, we brought together … Continue reading “10 Thoughts on the Future of Innovation From Boston 2034”

Core Informatics Garners $5,000,000 Series A Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b7dd9076-41d7-40d0-90de-5b720f813445 Date 6/11/2014 Company Name Core Informatics Mailing Address 500 E. Main Street Branford, CT 06405 USA Company Description Core Informatics provides innovative data management software to accelerate scientific discovery and collaboration. Website http://www.corelims.com Transaction Type Venture Equity Transaction Amount $5,000,000 Transaction Round Series A Proceeds Purposes The company intends to use … Continue reading “Core Informatics Garners $5,000,000 Series A Round”

Handybook Garners $30,000,000 Series B Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=86711e57-ba86-44de-a53f-cbe749c59e70 Date 6/11/2014 Company Name Handybook Mailing Address One Broadway 16th Floor Cambridge, MA 02142 USA Company Description Handybook is quite simply the easiest way to get stuff done around the house. Within a couple of minutes, you can book a pre-approved cleaner or handyman for whatever time you like. All you … Continue reading “Handybook Garners $30,000,000 Series B Financing Round”

XebiaLabs Secures $12,000,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dd53eaa6-b1b6-46f8-8023-f96b7ec90951 Date 6/10/2014 Company Name XebiaLabs Mailing Address 98 North Washington Street Boston, MA 02114 USA Company Description XebiaLabs is the leading global provider of automation software for DevOps and Continuous Delivery helping companies to accelerate the delivery of new software. XebiaLabs’ products provide the automation, efficiency and insight organizations need to … Continue reading “XebiaLabs Secures $12,000,000 New Financing”

Lou Tartaglia Leaves Third Rock to Run High-Drama RNAi Startup

[Updated 6/9/14, 3:55 pm. See below.] Solstice Biologics is announcing a new CEO today, and it’s a testament to the San Diego startup’s rollercoaster ride to say the news is one of the least dramatic events in Solstice’s short 18-month existence. New CEO and president Lou Tartaglia (pictured) has left Boston’s Third Rock Ventures, one … Continue reading “Lou Tartaglia Leaves Third Rock to Run High-Drama RNAi Startup”

East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More

Fresh off Memorial Day barbecues, the life sciences world descended on Chicago last week for the American Society of Clinical Oncology’s annual meeting. But it was quickly back to the grind afterward, with deals, IPO news, and much more filling up the headlines on the East Coast. —After a few years fine-tuning its investment strategy, … Continue reading “East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More”

Merck Scoops Up Idenix in $3.85B Buyout

Idenix Pharmaceuticals nearly became a footnote in the hepatitis C drug race a few years ago when Bristol-Myers Squibb’s buyout of Inhibitex imploded, kickstarting a series of events that led the FDA to slap clinical holds on two of the Cambridge, MA-based company’s drug prospects. Those who stayed with Idenix through the tough times are … Continue reading “Merck Scoops Up Idenix in $3.85B Buyout”

A $15 Minimum Wage Doesn’t Have to Mean Price Increases

Last week, Seattle approved the nation’s highest minimum wage: $15 an hour, to be phased in over the next seven years. Other major cities, including San Francisco, Chicago, and New York City, are debating similar increases, and President Obama has called for an increase in the federal minimum wage from $7.25 to $10.10 an hour. … Continue reading “A $15 Minimum Wage Doesn’t Have to Mean Price Increases”

Akebia, Trading M&A For an IPO, Follows Fast in Anemia Drug Race

Akebia Therapeutics and its investors had hit a crossroads familiar to many startup biotechs last year. Its lead drug, AKB-6548, a pill for the anemia people get when their kidneys are failing, had just produced good enough data to move it into a Phase 2b study. If that went well too, the company would need … Continue reading “Akebia, Trading M&A For an IPO, Follows Fast in Anemia Drug Race”

Seres Health Receives $10,000,000 Series B Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9f3c46c8-4679-4a2c-bb92-689237a23e5f Date 6/9/2014 Company Name Seres Health Mailing Address 161 First Street Cambridge, MA 02142 USA Company Description Seres Health is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic therapeutic products to treat important diseases by targeting the underlying biology of the human microbiome. Website http://www.sereshealth.com Transaction Type Venture … Continue reading “Seres Health Receives $10,000,000 Series B Funding Round”

Avitide Garners $3,435,003 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9d22687e-f553-48c6-bf48-a45db36e79c9 Date 6/9/2014 Company Name Avitide Mailing Address 7 Lucent Drive Lebanon, NH 03766 USA Company Description Avitide develops customized biopharmaceutical affinity purification products. The Avitide platform reduces bioprocess development timelines, program risk, and cost of manufacture by providing turnkey, cost-effective, highly specific affinity purification solutions. Website http://www.avitide.com Transaction Type Venture Equity … Continue reading “Avitide Garners $3,435,003 New Funding”

Post-IPO Biotechs Have News, But Big Pharma Drives the ASCO Boat

As often happens, industry news from the annual American Society of Clinical Oncology (ASCO) meeting, which ended Wednesday in Chicago, was dominated this year by Big Pharma. It’s not surprising—even with the advent of targeted cancer therapies that promise more precise treatment of smaller patient populations, clinical trials require big budgets. No drug giant had … Continue reading “Post-IPO Biotechs Have News, But Big Pharma Drives the ASCO Boat”